By continuing to use the site you agree to our Privacy & Cookies policy

Atypical fracture risk outweighed by bisphosphonates benefit

The risk of atypical fractures from taking bisphosphonates in people with osteoporosis is low, according to US researchers.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo